Ongoing trials

UT RIN-PF-301 – TETON-IPF

TETON-IPF is a phase III study of the molecule Treprostinil for slowing the progression and reducing the symptoms of idiopathic pulmonary fibrosis.

You may receive the investigational molecule or a placebo. The treatment is administered by inhalation.

To participate, you must have received a diagnosis of idiopathic pulmonary fibrosis.

Clic here to access the official record from the National Library of Medicine for this study.

Contact form

Once the form has been completed and submitted, a member of our team will contact you.

Please note that all information provided is kept confidential in a secure database and will be used for study recruitment purposes only.

By completing this form, you consent to share your information in accordance with our Terms of Use et privacy Policy.

Consent to cookies

This website uses cookies for its proper functioning and to analyze your interaction with it, in order to offer you a personalized and improved experience. We will only use cookies if you give your consent by clicking "Accept All". You also have the option to manage your cookie preferences by accessing the settings via the "Customize" button.

Customizing cookies

Analytics
Advertising
Other